Funding for this research was provided by:
Teva Pharmaceutical Industries (NA)
Received: 24 January 2020
Accepted: 21 September 2020
First Online: 15 October 2020
Ethics approval and consent to participate
: Ethical approval for the study was granted by the Ethics (Helsinki) Committee of the Israeli Ministry of Health [approval #0118–14]. Prior to participation in the study, all participants in the study signed an informed consent form, in accordance with the approval granted by the Ethics (Helsinki) Committee.
: Participants provided consent for publication of segments from their interviews, under the condition that such publication will not reveal in any way their identity.
: The authors declare that they have no competing interests.